Crossmark

Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic fibrosis

Crossref DOI link: https://doi.org/10.1038/s41598-019-38984-y

Published Online: 2019-02-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hahn, Andrea https://orcid.org/0000-0002-5117-0080
Fanous, Hani

Jensen, Caroline

Chaney, Hollis

Sami, Iman

Perez, Geovanny F.

Koumbourlis, Anastassios C.

Louie, Stan

Bost, James E.

van den Anker, John N.

Freishtat, Robert J.

Zemanick, Edith T.

Crandall, Keith A. https://orcid.org/0000-0002-0836-3389
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (K12HL119994)

U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1TR000075)

2nd Annual President's Award, Children's National Health System
License Information

Text and Data Mining valid from 2019-02-22

Version of Record valid from 2019-02-22
More Information

Article History

Received: 1 November 2018

Accepted: 4 January 2019

First Online: 22 February 2019

Competing Interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below